p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer

BACKGROUND: Despite advances in early diagnosis and treatment of cancer patients, metastasis remains the major cause of mortality. TP53 is one of the most frequently mutated genes in human cancer, and these alterations can occur during the early stages of oncogenesis or as later events as tumors pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, Emily, Shao, Jiansu, Yuan, Yuan, Chen, Hsiang-Chun, Cai, Shirong, Echeverria, Gloria V., Mistry, Nipun, Decker, Keith F., Schlosberg, Christopher, Do, Kim-Anh, Edwards, John R., Liang, Han, Piwnica-Worms, David, Piwnica-Worms, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728775/
https://www.ncbi.nlm.nih.gov/pubmed/26818199
http://dx.doi.org/10.1186/s13058-016-0673-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728775/
https://www.ncbi.nlm.nih.gov/pubmed/26818199
http://dx.doi.org/10.1186/s13058-016-0673-9

Ejemplares similares